Weekly Policy Update: State Releases Draft Proposal for Public Health Insurance Option

  On Monday, the Colorado Division of Insurance and the Department of Health Care Policy and Financing released a draft report on the development of the state’s plan for a public health insurance...

Learn More

Weekly Policy Update: CBSA Urges Congress to Reject Proposals that Adopt Foreign Price Controls

CBSA is committed to ensuring patients have access to the treatments they need. We appreciate the bipartisan efforts underway by the Trump Administration and Congress to provide patients relief from h...

Learn More

Weekly Policy Update: House Speaker Nancy Pelosi Releases Proposal on Prescription Drug Pricing

On September 19, House Speaker Nancy Pelosi released a long-anticipated proposal intended to reduce prescription drug prices. H.R. 3, the Lower Drug Costs Now Act of 2019, includes the following provi...

Learn More

Weekly Policy Update: Zimmer Biomet Spine Hosts Congressman Ed Perlmutter at Westminster Facility

At the end of August, Congressman Ed Perlmutter (CO-07) visited Zimmer Biomet Spine in Westminster to tour the medical education training facilities, biomechanics labs, and manufacturing area. Followi...

Learn More

Weekly Policy Update: CBSA Hosts Congressman Jason Crow (CO-06)

  This month CBSA partnered with Fitzsimons Innovation Community, Gates Biomanufacturing Facility and Sharklet Technologies to host Congressman Jason Crow (CO-06) for a campus tour and roundtable...

Learn More

Weekly Policy Update: CBSA Meets with Executive Director of OEDIT

  This week CBSA President & CEO Jennifer Jones Paton and Vice President Emily Roberts met with Betsy Markey, Executive Director of the Office of Economic Development and International Trade...

Learn More

Weekly Policy Update: Take Action! Join a New Letter Urging Congress to Prioritize Repeal of the Medical Device Tax

Last week we asked the Colorado bioscience community to take action and urge our Members of Congress to support permanent repeal of the medical device excise tax. The tax is a threat to medical innova...

Learn More

Weekly Policy Update: End the Device Tax

The Colorado BioScience Association strongly opposes the medical device tax, a 2.3% excise tax on the sale of certain medical technology that was enacted as part of the Affordable Care Act. Since its...

Learn More

Weekly Policy Update: HHS and FDA Announce Plan to Allow Importation of Prescription Drugs

This week the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) released a plan that describes the steps they will take to allow importation of certain drugs fro...

Learn More

Weekly Policy Update: Senate Finance Committee Advances Drug Pricing Package

On Thursday, the Senate Finance Committee advanced a major legislative package that includes substantial changes to Medicare and Medicaid drug reimbursement. The bill, the Prescription Drug Pricing Re...

Learn More